大数据背景下提升药品经营质量管理改革探索

Exploration of Management Reform to Improve the Quality of Pharmaceutical Business under the Background of Big Data

近年来,"互联网+"战略在各个行业持续推进,同时伴随着大数据技术的不断发展,对药品企业亦提出了新要求。在药品经营管理过程中,借助大数据技术可在很大程度上规范药品经营质量管理,提高药品可追溯,降低药品安全风险。基于此,本文以大数据相关概念为切入点,对大数据背景下医药行业的发展现状进行了分析,接着提出了药品经营管理改革的具体措施,最后从数据层面剖析改革过程中的注意事项,以期能够为我国药品经营企业的可持续发展、提升药品经营质量管理提供参考借鉴。

In recent years,the“Internet+”strategy has continued to advance in various industries.At the same time,with the continuous development of big data technology,new requirements have also been put forward for pharmaceutical companies.In the process of drug business management,the use of big data technology can standardize drug business quality management to a large extent,improve drug traceability,and reduce drug safety risks.Based on this,this article uses big data-related concepts as an entry point to analyze the development status of the pharmaceutical industry in the context of big data,and then proposes specific measures for the reform of drug business management,and finally analyzes the precautions in the reform process from the data level.It is hoped that it can provide reference for the sustainable development of my country’s pharmaceutical business enterprises and the improvement of pharmaceutical business quality management.